From trial phases to personalized care, here’s how healthcare providers can navigate cancer clinical trials and guide ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Onc.AI is a digital health company developing AI-driven oncology clinical management solutions using advanced Deep Learning applied to routine diagnostic images. The company's platform is applied at ...

A first-of-its-kind clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobulin ...

The landscape of neurology biomarkers has evolved significantly in recent years, affording new clinical insights that are ...

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.A new Phase 2 clinical ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Parkinson's disease is best known for its effects on the central nervous system. In addition, recent scientific advances ...